1 Study Coverage
    1.1 Oral Live Cholera Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global Oral Live Cholera Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Dukoral
        1.2.3 Shanchol
        1.2.4 Vaxchora
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Oral Live Cholera Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Scientific Research
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Oral Live Cholera Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global Oral Live Cholera Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Oral Live Cholera Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Oral Live Cholera Vaccines Sales by Region
        2.4.1 Global Oral Live Cholera Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales Oral Live Cholera Vaccines by Region (2023-2028)
    2.5 Global Oral Live Cholera Vaccines Revenue by Region
        2.5.1 Global Oral Live Cholera Vaccines Revenue by Region (2017-2022)
        2.5.2 Global Oral Live Cholera Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Oral Live Cholera Vaccines Sales by Manufacturers
        3.1.1 Global Top Oral Live Cholera Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global Oral Live Cholera Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Live Cholera Vaccines in 2021
    3.2 Global Oral Live Cholera Vaccines Revenue by Manufacturers
        3.2.1 Global Oral Live Cholera Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Oral Live Cholera Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Oral Live Cholera Vaccines Revenue in 2021
    3.3 Global Oral Live Cholera Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Oral Live Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Oral Live Cholera Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Oral Live Cholera Vaccines Sales by Type
        4.1.1 Global Oral Live Cholera Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global Oral Live Cholera Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Oral Live Cholera Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global Oral Live Cholera Vaccines Revenue by Type
        4.2.1 Global Oral Live Cholera Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global Oral Live Cholera Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Oral Live Cholera Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global Oral Live Cholera Vaccines Price by Type
        4.3.1 Global Oral Live Cholera Vaccines Price by Type (2017-2022)
        4.3.2 Global Oral Live Cholera Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Oral Live Cholera Vaccines Sales by Application
        5.1.1 Global Oral Live Cholera Vaccines Historical Sales by Application (2017-2022)
        5.1.2 Global Oral Live Cholera Vaccines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Oral Live Cholera Vaccines Sales Market Share by Application (2017-2028)
    5.2 Global Oral Live Cholera Vaccines Revenue by Application
        5.2.1 Global Oral Live Cholera Vaccines Historical Revenue by Application (2017-2022)
        5.2.2 Global Oral Live Cholera Vaccines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Oral Live Cholera Vaccines Revenue Market Share by Application (2017-2028)
    5.3 Global Oral Live Cholera Vaccines Price by Application
        5.3.1 Global Oral Live Cholera Vaccines Price by Application (2017-2022)
        5.3.2 Global Oral Live Cholera Vaccines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Oral Live Cholera Vaccines Market Size by Type
        6.1.1 North America Oral Live Cholera Vaccines Sales by Type (2017-2028)
        6.1.2 North America Oral Live Cholera Vaccines Revenue by Type (2017-2028)
    6.2 North America Oral Live Cholera Vaccines Market Size by Application
        6.2.1 North America Oral Live Cholera Vaccines Sales by Application (2017-2028)
        6.2.2 North America Oral Live Cholera Vaccines Revenue by Application (2017-2028)
    6.3 North America Oral Live Cholera Vaccines Market Size by Country
        6.3.1 North America Oral Live Cholera Vaccines Sales by Country (2017-2028)
        6.3.2 North America Oral Live Cholera Vaccines Revenue by Country (2017-2028)
        6.3.3 the United States
        6.3.4 Canada
7 Europe
    7.1 Europe Oral Live Cholera Vaccines Market Size by Type
        7.1.1 Europe Oral Live Cholera Vaccines Sales by Type (2017-2028)
        7.1.2 Europe Oral Live Cholera Vaccines Revenue by Type (2017-2028)
    7.2 Europe Oral Live Cholera Vaccines Market Size by Application
        7.2.1 Europe Oral Live Cholera Vaccines Sales by Application (2017-2028)
        7.2.2 Europe Oral Live Cholera Vaccines Revenue by Application (2017-2028)
    7.3 Europe Oral Live Cholera Vaccines Market Size by Country
        7.3.1 Europe Oral Live Cholera Vaccines Sales by Country (2017-2028)
        7.3.2 Europe Oral Live Cholera Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 UK
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Oral Live Cholera Vaccines Market Size by Type
        8.1.1 Asia Pacific Oral Live Cholera Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Oral Live Cholera Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific Oral Live Cholera Vaccines Market Size by Application
        8.2.1 Asia Pacific Oral Live Cholera Vaccines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Oral Live Cholera Vaccines Revenue by Application (2017-2028)
    8.3 Asia Pacific Oral Live Cholera Vaccines Market Size by Region
        8.3.1 Asia Pacific Oral Live Cholera Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Oral Live Cholera Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Oral Live Cholera Vaccines Market Size by Type
        9.1.1 Latin America Oral Live Cholera Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America Oral Live Cholera Vaccines Revenue by Type (2017-2028)
    9.2 Latin America Oral Live Cholera Vaccines Market Size by Application
        9.2.1 Latin America Oral Live Cholera Vaccines Sales by Application (2017-2028)
        9.2.2 Latin America Oral Live Cholera Vaccines Revenue by Application (2017-2028)
    9.3 Latin America Oral Live Cholera Vaccines Market Size by Country
        9.3.1 Latin America Oral Live Cholera Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America Oral Live Cholera Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Oral Live Cholera Vaccines Market Size by Type
        10.1.1 Middle East and Africa Oral Live Cholera Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Oral Live Cholera Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Oral Live Cholera Vaccines Market Size by Application
        10.2.1 Middle East and Africa Oral Live Cholera Vaccines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Oral Live Cholera Vaccines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Oral Live Cholera Vaccines Market Size by Country
        10.3.1 Middle East and Africa Oral Live Cholera Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Oral Live Cholera Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Valneva
        11.1.1 Valneva Corporation Information
        11.1.2 Valneva Overview
        11.1.3 Valneva Oral Live Cholera Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Valneva Oral Live Cholera Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Valneva Recent Developments
    11.2 PaxVax
        11.2.1 PaxVax Corporation Information
        11.2.2 PaxVax Overview
        11.2.3 PaxVax Oral Live Cholera Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 PaxVax Oral Live Cholera Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 PaxVax Recent Developments
    11.3 Shantha Biotechnics Limited
        11.3.1 Shantha Biotechnics Limited Corporation Information
        11.3.2 Shantha Biotechnics Limited Overview
        11.3.3 Shantha Biotechnics Limited Oral Live Cholera Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Shantha Biotechnics Limited Oral Live Cholera Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Shantha Biotechnics Limited Recent Developments
    11.4 Celldex Therapeutics
        11.4.1 Celldex Therapeutics Corporation Information
        11.4.2 Celldex Therapeutics Overview
        11.4.3 Celldex Therapeutics Oral Live Cholera Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Celldex Therapeutics Oral Live Cholera Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Celldex Therapeutics Recent Developments
    11.5 Merck
        11.5.1 Merck Corporation Information
        11.5.2 Merck Overview
        11.5.3 Merck Oral Live Cholera Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Merck Oral Live Cholera Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Merck Recent Developments
    11.6 Ceva Asia
        11.6.1 Ceva Asia Corporation Information
        11.6.2 Ceva Asia Overview
        11.6.3 Ceva Asia Oral Live Cholera Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Ceva Asia Oral Live Cholera Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Ceva Asia Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Oral Live Cholera Vaccines Industry Chain Analysis
    12.2 Oral Live Cholera Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Oral Live Cholera Vaccines Production Mode & Process
    12.4 Oral Live Cholera Vaccines Sales and Marketing
        12.4.1 Oral Live Cholera Vaccines Sales Channels
        12.4.2 Oral Live Cholera Vaccines Distributors
    12.5 Oral Live Cholera Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Oral Live Cholera Vaccines Industry Trends
    13.2 Oral Live Cholera Vaccines Market Drivers
    13.3 Oral Live Cholera Vaccines Market Challenges
    13.4 Oral Live Cholera Vaccines Market Restraints
14 Key Findings in The Global Oral Live Cholera Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Oral Live Cholera Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Dukoral
    Table 3. Major Manufacturers of Shanchol
    Table 4. Major Manufacturers of Vaxchora
    Table 5. Major Manufacturers of Others
    Table 6. Global Oral Live Cholera Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Oral Live Cholera Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Oral Live Cholera Vaccines Sales by Region (2017-2022) & (K Units)
    Table 9. Global Oral Live Cholera Vaccines Sales Market Share by Region (2017-2022)
    Table 10. Global Oral Live Cholera Vaccines Sales by Region (2023-2028) & (K Units)
    Table 11. Global Oral Live Cholera Vaccines Sales Market Share by Region (2023-2028)
    Table 12. Global Oral Live Cholera Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Oral Live Cholera Vaccines Revenue Market Share by Region (2017-2022)
    Table 14. Global Oral Live Cholera Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Oral Live Cholera Vaccines Revenue Market Share by Region (2023-2028)
    Table 16. Global Oral Live Cholera Vaccines Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Oral Live Cholera Vaccines Sales Share by Manufacturers (2017-2022)
    Table 18. Global Oral Live Cholera Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Oral Live Cholera Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 20. Oral Live Cholera Vaccines Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Oral Live Cholera Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Oral Live Cholera Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Live Cholera Vaccines as of 2021)
    Table 23. Oral Live Cholera Vaccines Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Oral Live Cholera Vaccines Product Offered
    Table 25. Date of Manufacturers Enter into Oral Live Cholera Vaccines Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Oral Live Cholera Vaccines Sales by Type (2017-2022) & (K Units)
    Table 28. Global Oral Live Cholera Vaccines Sales by Type (2023-2028) & (K Units)
    Table 29. Global Oral Live Cholera Vaccines Sales Share by Type (2017-2022)
    Table 30. Global Oral Live Cholera Vaccines Sales Share by Type (2023-2028)
    Table 31. Global Oral Live Cholera Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Oral Live Cholera Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Oral Live Cholera Vaccines Revenue Share by Type (2017-2022)
    Table 34. Global Oral Live Cholera Vaccines Revenue Share by Type (2023-2028)
    Table 35. Oral Live Cholera Vaccines Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Oral Live Cholera Vaccines Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Oral Live Cholera Vaccines Sales by Application (2017-2022) & (K Units)
    Table 38. Global Oral Live Cholera Vaccines Sales by Application (2023-2028) & (K Units)
    Table 39. Global Oral Live Cholera Vaccines Sales Share by Application (2017-2022)
    Table 40. Global Oral Live Cholera Vaccines Sales Share by Application (2023-2028)
    Table 41. Global Oral Live Cholera Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Oral Live Cholera Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Oral Live Cholera Vaccines Revenue Share by Application (2017-2022)
    Table 44. Global Oral Live Cholera Vaccines Revenue Share by Application (2023-2028)
    Table 45. Oral Live Cholera Vaccines Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Oral Live Cholera Vaccines Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Oral Live Cholera Vaccines Sales by Type (2017-2022) & (K Units)
    Table 48. North America Oral Live Cholera Vaccines Sales by Type (2023-2028) & (K Units)
    Table 49. North America Oral Live Cholera Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Oral Live Cholera Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Oral Live Cholera Vaccines Sales by Application (2017-2022) & (K Units)
    Table 52. North America Oral Live Cholera Vaccines Sales by Application (2023-2028) & (K Units)
    Table 53. North America Oral Live Cholera Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Oral Live Cholera Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Oral Live Cholera Vaccines Sales by Country (2017-2022) & (K Units)
    Table 56. North America Oral Live Cholera Vaccines Sales by Country (2023-2028) & (K Units)
    Table 57. North America Oral Live Cholera Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Oral Live Cholera Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Oral Live Cholera Vaccines Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Oral Live Cholera Vaccines Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Oral Live Cholera Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Oral Live Cholera Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Oral Live Cholera Vaccines Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Oral Live Cholera Vaccines Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Oral Live Cholera Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Oral Live Cholera Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Oral Live Cholera Vaccines Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Oral Live Cholera Vaccines Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Oral Live Cholera Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Oral Live Cholera Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Oral Live Cholera Vaccines Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Oral Live Cholera Vaccines Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Oral Live Cholera Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Oral Live Cholera Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Oral Live Cholera Vaccines Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Oral Live Cholera Vaccines Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Oral Live Cholera Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Oral Live Cholera Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Oral Live Cholera Vaccines Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Oral Live Cholera Vaccines Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Oral Live Cholera Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Oral Live Cholera Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Oral Live Cholera Vaccines Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Oral Live Cholera Vaccines Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Oral Live Cholera Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Oral Live Cholera Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Oral Live Cholera Vaccines Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Oral Live Cholera Vaccines Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Oral Live Cholera Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Oral Live Cholera Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Oral Live Cholera Vaccines Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Oral Live Cholera Vaccines Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Oral Live Cholera Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Oral Live Cholera Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Oral Live Cholera Vaccines Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Oral Live Cholera Vaccines Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Oral Live Cholera Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Oral Live Cholera Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Oral Live Cholera Vaccines Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Oral Live Cholera Vaccines Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Oral Live Cholera Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Oral Live Cholera Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Oral Live Cholera Vaccines Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Oral Live Cholera Vaccines Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Oral Live Cholera Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Oral Live Cholera Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Valneva Corporation Information
    Table 108. Valneva Description and Major Businesses
    Table 109. Valneva Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Valneva Oral Live Cholera Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Valneva Recent Developments
    Table 112. PaxVax Corporation Information
    Table 113. PaxVax Description and Major Businesses
    Table 114. PaxVax Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. PaxVax Oral Live Cholera Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. PaxVax Recent Developments
    Table 117. Shantha Biotechnics Limited Corporation Information
    Table 118. Shantha Biotechnics Limited Description and Major Businesses
    Table 119. Shantha Biotechnics Limited Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Shantha Biotechnics Limited Oral Live Cholera Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Shantha Biotechnics Limited Recent Developments
    Table 122. Celldex Therapeutics Corporation Information
    Table 123. Celldex Therapeutics Description and Major Businesses
    Table 124. Celldex Therapeutics Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Celldex Therapeutics Oral Live Cholera Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Celldex Therapeutics Recent Developments
    Table 127. Merck Corporation Information
    Table 128. Merck Description and Major Businesses
    Table 129. Merck Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Merck Oral Live Cholera Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Merck Recent Developments
    Table 132. Ceva Asia Corporation Information
    Table 133. Ceva Asia Description and Major Businesses
    Table 134. Ceva Asia Oral Live Cholera Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Ceva Asia Oral Live Cholera Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Ceva Asia Recent Developments
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Oral Live Cholera Vaccines Distributors List
    Table 140. Oral Live Cholera Vaccines Customers List
    Table 141. Oral Live Cholera Vaccines Market Trends
    Table 142. Oral Live Cholera Vaccines Market Drivers
    Table 143. Oral Live Cholera Vaccines Market Challenges
    Table 144. Oral Live Cholera Vaccines Market Restraints
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oral Live Cholera Vaccines Product Picture
    Figure 3. Global Oral Live Cholera Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Dukoral Product Picture
    Figure 4. Shanchol Product Picture
    Figure 5. Vaxchora Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Oral Live Cholera Vaccines Market Share by Application in 2021 & 2028
    Figure 8. Hospital
    Figure 9. Scientific Research
    Figure 10. Others
    Figure 11. Oral Live Cholera Vaccines Report Years Considered
    Figure 12. Global Oral Live Cholera Vaccines Sales 2017-2028 (K Units)
    Figure 13. Global Oral Live Cholera Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Oral Live Cholera Vaccines Revenue 2017-2028 (US$ Million)
    Figure 15. Global Oral Live Cholera Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Oral Live Cholera Vaccines Sales Market Share by Region (2017-2022)
    Figure 17. Global Oral Live Cholera Vaccines Sales Market Share by Region (2023-2028)
    Figure 18. North America Oral Live Cholera Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Oral Live Cholera Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Oral Live Cholera Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Oral Live Cholera Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Oral Live Cholera Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Oral Live Cholera Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Oral Live Cholera Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Oral Live Cholera Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Oral Live Cholera Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Oral Live Cholera Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Oral Live Cholera Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Oral Live Cholera Vaccines in the World: Market Share by Oral Live Cholera Vaccines Revenue in 2021
    Figure 30. Global Oral Live Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Oral Live Cholera Vaccines Sales Market Share by Type (2017-2028)
    Figure 32. Global Oral Live Cholera Vaccines Revenue Market Share by Type (2017-2028)
    Figure 33. Global Oral Live Cholera Vaccines Sales Market Share by Application (2017-2028)
    Figure 34. Global Oral Live Cholera Vaccines Revenue Market Share by Application (2017-2028)
    Figure 35. North America Oral Live Cholera Vaccines Sales Market Share by Type (2017-2028)
    Figure 36. North America Oral Live Cholera Vaccines Revenue Market Share by Type (2017-2028)
    Figure 37. North America Oral Live Cholera Vaccines Sales Market Share by Application (2017-2028)
    Figure 38. North America Oral Live Cholera Vaccines Revenue Market Share by Application (2017-2028)
    Figure 39. North America Oral Live Cholera Vaccines Sales Share by Country (2017-2028)
    Figure 40. North America Oral Live Cholera Vaccines Revenue Share by Country (2017-2028)
    Figure 41. the United States Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Oral Live Cholera Vaccines Sales Market Share by Type (2017-2028)
    Figure 44. Europe Oral Live Cholera Vaccines Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Oral Live Cholera Vaccines Sales Market Share by Application (2017-2028)
    Figure 46. Europe Oral Live Cholera Vaccines Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Oral Live Cholera Vaccines Sales Share by Country (2017-2028)
    Figure 48. Europe Oral Live Cholera Vaccines Revenue Share by Country (2017-2028)
    Figure 49. Germany Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. France Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. UK Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Oral Live Cholera Vaccines Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Oral Live Cholera Vaccines Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Oral Live Cholera Vaccines Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Oral Live Cholera Vaccines Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Oral Live Cholera Vaccines Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Oral Live Cholera Vaccines Revenue Share by Region (2017-2028)
    Figure 60. China Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. India Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. China Taiwan Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Oral Live Cholera Vaccines Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Oral Live Cholera Vaccines Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Oral Live Cholera Vaccines Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Oral Live Cholera Vaccines Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Oral Live Cholera Vaccines Sales Share by Country (2017-2028)
    Figure 74. Latin America Oral Live Cholera Vaccines Revenue Share by Country (2017-2028)
    Figure 75. Mexico Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Oral Live Cholera Vaccines Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Oral Live Cholera Vaccines Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Oral Live Cholera Vaccines Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Oral Live Cholera Vaccines Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Oral Live Cholera Vaccines Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Oral Live Cholera Vaccines Revenue Share by Country (2017-2028)
    Figure 84. Turkey Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Oral Live Cholera Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 87. Oral Live Cholera Vaccines Value Chain
    Figure 88. Oral Live Cholera Vaccines Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed